Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

809129

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	What recent assessment he has made of trends in the level of fines in relation to dental and prescription charges.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	903036
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The NHS Business Services Authority (NHS BSA) issues penalty charge notices (PCNs) for incorrect claims for exemption from National Health Service dental and prescription charges.</p><p>To ensure the integrity of the exemption system the NHS BSA has recently increased the number of checks. In 2016/17, 365,181 PCNs for dental charges and 975,065 for prescription charges were issued. This represents an increase of 90.11% and 90.23%, respectively, on 2015/16. There is a clear process for patients to appeal a PCN if they believe it is unjustified.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:09:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

809126

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Skin Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	What estimate he has made of the number of patients with Erythropoietic Protoporphyria.
	tabling member constituency	Newport East
	tabling member printed	Jessica Morden
	uin	903031
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In 2016/17 there were 54 National Health Service admissions in England with a primary diagnosis of Erythropoietic Protoporphyria.</p><p> </p><p>Whilst the numbers of people with a particular rare disease can be very small, 3.5 million people in the United Kingdom have a rare disease. We know, as with the hon. Member’s constituent, that these diseases can have a heart-breaking impact on a person’s health.</p><p> </p><p>That‘s why the UK is committed to building on our position as a world-leader in the diagnosis and treatment of rare diseases.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:07:30 answering member 4067 label Biography information for Steve Brine
	tabling member	1548 label Biography information for Jessica Morden

828794

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State, if he will take steps to ensure that people with diabetes are offered urine and blood tests to check for chronic kidney disease.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	124426
	answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published guidance on ‘Chronic kidney disease in adults’ which sets out best practice for clinicians on the diagnosis, treatment, care, and support of patients with chronic kidney disease (CKD). The guidance also includes recommendations for those at risk of developing CKD, including people with diabetes. NHS England expects commissioners to take account of NICE guidelines when delivering services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/01/2018 12:34:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

807191

	registered interest
	date	15/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the commercial agreement announced by NHS England on 9 November 2017, what the timetable is for NICE to issue final guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer.
	tabling member constituency	North Warwickshire
	tabling member printed	Craig Tracey
	uin	119837
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>The timetable for the National Institute for Health and Care Excellence’s (NICE) guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer is still to be confirmed. Perjeta remains available to new and existing National Health Service patients through the Cancer Drugs Fund pending NICE’s final guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:38:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4509 label Biography information for Craig Tracey

804559

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the NHS England document, Next Steps on the Five Year Forward View published in March 2017, what recent progress the NHS has made on meeting the objective for an extra 5,000 people to survive cancer over the next two years.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118761
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>Earlier and faster diagnosis is key to improving survival rates and NHS England is investing over £200 million over the next two years in cancer services to encourage local areas to find new and innovative ways to diagnose cancer earlier, improve the care for those living with cancer and ensure each cancer patient gets the right care for them. The Government has also committed £130 million for new technology and equipment to ensure patients have access to the best and latest radiotherapy treatment.</p><p> </p><p>Survival rates from cancer in England are at a record high, and since 2010 rates of survival from cancer have increased year-on-year. The decrease in cancer deaths means that around 7,000 people are alive today who would not have been had things stayed the same. One year survival rates for the period 2017-19 will be available in 2021.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:30:05 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

818651

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	uin	121415
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:04:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4412 label Biography information for Dr Lisa Cameron

818756

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	High Weald Lewes Havens Clinical Commissioning Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 8 November 2016 to Question 51429, if he will publish a copy of the validated analysis of costs provided by Coperforma Ltd to the High Weald Havens Clinical Commissioning Group referred to in that Answer; what the value is of invoices the High Weald Havens Clinical Commissioning Group received directly from each trust which incurred private ambulance costs arising from performance problems with Patient Transport Services provided by Coperforma and arms length driver operatives; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	121520
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121517 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

805229

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to NHS England's press release of 28 July 2016 entitled World Hepatitis Day: a chance to reflect on achievements to date and redouble efforts, what discussions his Department has had with NHS England on developing more innovative, longer-term proposals for the treatment of hepatitis C.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118901
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>Following a procurement process that concluded in September 2017, NHS England has secured further improvements in pricing of hepatitis C treatments, including through an innovative ‘pay per cure’ approach. NHS England’s detailed work to design an innovative, longer-term approach to hepatitis C treatment procurement has continued and it is anticipated that this will be shared with suppliers early in 2018.</p><p> </p><p>NHS England spent in excess of £200 million on direct acting antivirals for hepatitis C in 2016-17 and is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence, apportioned to local Operational Delivery Networks based on estimated local health needs.</p><p> </p><p>NHS England is planning a sustainable roll out of treatment which will complete the treatment of 71,000 individuals between 2015/16 and 2020/21.</p><p> </p><p>Commercial and contractual activity undertaken by NHS England is already securing reduced prices to allow expanded treatment rates within available resources.</p><p> </p><p>Various initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres recognising the challenges inherent in a pathway where there are multiple commissioners and providers and budgetary constraints.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:27:51 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

809659

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to Age UK’s Painful Journeys campaign, what steps his Department is taking to make travelling to and from hospital easier for older people.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	120279
	answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>The provision of appropriate patient transport services (PTS) in line with national guidance is a matter for local National Health Service commissioners.</p><p> </p><p>The Department is clear that medically eligible patients must have appropriate access to quality PTS to outpatient appointments. The document ‘Eligibility Criteria for Patient Transport Services’ sets out criteria for establishing which patients are eligible for non-emergency PTS. The guidance states that eligible patients should reach appointments in reasonable time and in reasonable comfort, without detriment to their medical condition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:03:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4058 label Biography information for Paul Blomfield

810724

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, who is responsible for determining the membership of an Accountable Care Organisation.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	121069
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>In the very small number of places where local commissioners are running procurements for the award of such contracts, local National Health Service foundation trusts, NHS trusts and general practitioners have been selected as partners for delivery of those contracts.</p><p> </p><p>The selection of an appropriate provider to hold such a contract will continue to be a matter for local NHS commissioners, and those commissioners must make that selection by way of a process which is compliant with the requirements of the Public Contract Regulations 2015. These involve openness, transparency and equal treatment of potential providers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120591 question first answered 11/01/2018 16:52:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders